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Abstract
Background: Protein Kinase D (PKD) is an effector of diacylglycerol-regulated signaling pathways.
Three isoforms are known in mammals that have been linked to diverse cellular functions including
regulation of cell proliferation, differentiation, motility and secretory transport from the trans-
Golgi network to the plasma membrane. In Drosophila, there is a single PKD orthologue, whose
broad expression implicates a more general role in development.
Results: We have employed tissue specific overexpression of various PKD variants as well as
tissue specific RNAi, in order to investigate the function of the PKD gene in Drosophila. Apart from
a wild type (WT), a kinase dead (kd) and constitutively active (SE) Drosophila PKD variant, we also
analyzed two human isoforms hPKD2 and hPKD3 for their capacity to substitute PKD activity in
the fly. Overexpression of either WT or kd-PKD variants affected primarily wing vein development.
However, overexpression of SE-PKD and PKD RNAi was deleterious. We observed tissue loss,
wing defects and degeneration of the retina. The latter phenotype conforms to a role of PKD in
the regulation of cytoskeletal dynamics. Strongest phenotypes were larval to pupal lethality. RNAi
induced phenotypes could be rescued by a concurrent overexpression of Drosophila wild type PKD
or either human isoform hPKD2 and hPKD3.
Conclusion: Our data confirm the hypothesis that Drosophila PKD is a multifunctional kinase
involved in diverse processes such as regulation of the cytoskeleton, cell proliferation and death as
well as differentiation of various fly tissues.
Background
Protein kinases D (PKD) are serine/threonine-specific
kinases that belong to the subfamily of Ca(2+)/Calmodu-
lin kinases. They are effectors in diacylglycerol-regulated
signaling pathways. In mammals, three highly related
PKDs 1–3 (in human named also PKCμ, PKD2 and PKCν)
are known [1]. PKD contains two domains, a regulatory
domain and a catalytic kinase domain. The regulatory
domain inhibits the kinase domain, until the enzyme is
activated by phosphorylation of two serine residues
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described to activate PKD1 [2]. As consequence of a
mitotic signal, diacylglycerol is generated by phospholi-
pase C stimulation, resulting in the activation of either
novel protein kinase C, PKCε or PKCη, which in turn
phosphorylate PKD1 [3,4]. Alternatively, PKD1 is acti-
vated by Gβγ that binds to the regulatory domain, thereby
abrogating its inhibitory function [5]. Finally, in response
to genotoxic stress, the kinase domain can be released by
Caspase-mediated cleavage [6,7]. However, a PKD homo-
logue in C. elegans DKF-1 (D-kinase factor 1) is directly
activated by phorbol-esters independent of PKC [8]. PKDs
are found within different subcellular compartments in
agreement with their multiple biological roles in highly
diverse cellular processes including cell proliferation and
apoptosis, cell migration, cellular differentiation and
notably, cargo specific secretory transport from the trans-
Golgi network (TGN) to the plasma membrane [1,2]. The
involvement of PKD in the regulation of fission of secre-
tory vesicles from TGN was deduced primarily from over-
expression experiments of a presumptive dominant
negative PKD variant, which bears a single amino acid
substitution in the ATP binding domain and therefore
lacks kinase activity ('kinase dead') [9-11]. 'Kinase dead'
PKD interferes with the fission of vesicles at the TGN
owing to a tubularization of Golgi membranes [10]. The
relevance of these observations is strengthened by the
finding that one of the physiological substrates of PKD1
and PKD2 is phosphatidylinositol-4 kinase III beta
(PI4KIIIβ), which is central to Golgi structure and func-
tion [9]. Apart from its role in secretory transport, trans-
genic mouse models reveal the importance of PKD for
differentiation of T lymphocytes [12]. Moreover, mutants
of the corresponding C. elegans kinase DKF-1 displayed
body paralysis, whereas overexpression caused growth
defects [8].
The Drosophila genome harbors a single PKD homologue.
As expected for a multifunctional protein, PKD is broadly
expressed during development. A fraction of the PKD pro-
tein localizes to the Golgi compartment in agreement
with a proposed role in secretory transport [13]. Hence,
Drosophila may serve as model system to investigate the in
vivo function of PKD. To this end, we have analyzed the
phenotypic consequences of overexpression of wild type
and mutant PKD variants on the development of a
number of tissues, the consequences of tissue specific
RNA-interference and the capacity of human hPKD2 and
hPKD3 to substitute for Drosophila PKD. Only slight
defects primarily during wing vein development were
observed upon overexpression of wild type (WT) or kd-
variants, whereas overexpression of a constitutively active
form is deleterious to fly development, as is PKD RNAi.
Our data are in accordance with a role for PKD in the reg-
ulation of cytoskeletal dynamics, cell proliferation and




Mammalian PKD is a multifunctional kinase regulating
diverse processes including proliferation, apoptosis and
secretory transport [1,2]. The lack of mutants hampers a
direct analysis of PKD's role in Drosophila. In order to
address the possible functions of PKD in the fly, we exam-
ined the consequences of overexpression of wild type, pre-
sumptive dominant negative and constitutively active
PKD variants as well as of PKD depletion by RNA interfer-
ence. Several UAS-constructs were generated (see Figure
1A) that allow tissue specific overexpression using the
Gal4/UAS-system [14]. The PKD-WT construct expresses
the PKD wild type protein fused to GFP [13]. To generate
a 'kinase dead' (kd) PKD-construct, lysine K572 was
replaced by tryptophan in order to destroy the presump-
tive ATP-binding domain. The resultant PKD protein was
expected to be a dominant negative isoform according to
earlier reports on respective changes in mammalian PKDs
[9-11,15]. A constitutive active protein PKD-SE was gener-
ated by replacing two serine residues S698 and S702 with
glutamate. These two serines are located within the activa-
tion loop and are presumably phosphorylated upon acti-
vation of PKD in analogy to respective observations on
mammalian PKDs [13,16]. Likewise changes have been
reported to generate constitutive active forms of human
PKD as well [16,17]. Both variants, PKD-kd and PKD-SE
were made as C-terminal fusion to GFP in order to facili-
tate their in vivo detection (Fig. 1A). The human isoforms
hPKD2 and hPKD3 (i.e. PKD2 and PKCν respectively)
[18,19] were likewise fused to GFP and cloned as UAS-
overexpression constructs. They were chosen as a more
diverse (hPKD2) and the most similar (hPKD3) in com-
parison with Drosophila PKD [13]. Finally, a large portion
of the kinase domain (codons 582 – 836) [13] was cloned
in inverted and direct orientation, split by a small intron
into pUAST to generate dsPKD. This construct is expected
to produce a double stranded RNA transcript [20], result-
ing in tissue specific RNA interference and hence, deple-
tion of PKD activity. Figure 1A gives an overview of the
different constructs. Several independent transgenic lines
were generated from each construct and compared for
their expressivity. PKD expression was monitored on
Western blots and in situ in larval tissues making use of the
GFP-tag (Fig. 1B–E, and data not shown) [13]. Finally, at
least five strains of each construct were compared in over-
expression experiments for their phenotypes; typical
strains were used in subsequent experiments.Page 2 of 13
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Human PKD has been reported to regulate secretory trans-
port from the TGN to the plasma membrane [10]. To
investigate whether the PKD-kd and -SE variants are inter-
fering with secretory transport, we made use of a plasmid
encoding horseradish peroxidase (HRP) fused to a signal
sequence. The fusion protein ss-HRP can be used as a
reporter for constitutive protein secretion [21]. We trans-
fected HEK293 cells with plasmids encoding for ss-HRP
and PKD-WT, -kd or -SE and measured the secretion of ss-
HRP over time. In control cells, secretion of ss-HRP could
be detected within 1 hour and increased over time (Fig.
2A). Co-expression of PKD-kd inhibited the secretion of
ss-HRP into the supernatant, whereas co-expression of
PKD-SE increased the amount of secreted HRP compared
to the control. Expression of PKD-WT had no effect on
secretion of ss-HRP in this system. It has been demon-
strated, that expression of a kinase dead PKD variant leads
to tubularization of the TGN [10]. We therefore investi-
gated, whether expression of Drosophila PKD-kd displays
similar effects. Unfortunately, changes in Golgi-morphol-
ogy are difficult to detect in Drosophila cells due to their
small size [21,22], which hampers an analysis in this sys-
tem. Therefore we transfected COS7 cells with plasmids
encoding Drosophila PKD-WT, -kd and -SE proteins fused
to GFP. PKD-WT and PKD-SE displayed a similar localiza-
tion; both proteins were predominantly localized in the
cytoplasm with a small portion of the protein enriched at
a perinuclear structure, which presents the Golgi compart-
ment ([13] and Fig. 2B). In contrast, PKD-kd was strongly
enriched at the Golgi compartment and induced the for-
mation of tubules. This is in accordance with the pheno-
type induced by expression of mammalian dominant
negative PKD-kd variants [10].
Overexpression of PKD interferes with wing development
In a first set of experiments, the consequences of overex-
pression of PKD variants on adult flies were monitored.
The PKD variants were ubiquitously overexpressed using
the da-Gal4 driver line and within the posterior wing
compartment using the en-Gal4 driver line, respectively.
Induction of either PKD-WT or PKD-kd variants interfered
with formation of wing veins (Figure 3B–E). The posterior
cross vein was frequently affected and incompletely devel-
oped. In addition to massive vein loss, PKD-kd induced
ectopic veins, mostly abutting the second and less often
the fifth longitudial vein, when overexpressed uniformly
during larval development (Figure 3D,E).
Ubiquitous overexpression of PKD-SE and dsPKD dis-
rupted fly development. Offspring from a cross of da-Gal4
with UAS-PKD-SE all died at first larval instar larva at
18°C and at 25°C. Most da > dsPKD animals died as pre-
pupae at 25°C and only few started pupation (13 of 207);
PKD variants and activityFigure 1
PKD variants and activity. A) Schematic representation 
of Drosophila wild type and mutant UAS-PKD variants, PKD-
WT, PKD-kd, PKD-SE, dsPKD and human PKD variants, 
hPKD2 and hPKD3. Apart from dsPKD, all proteins were 
expressed as GFP fusion proteins. PKD contains a regulatory 
domain and a kinase domain. The characteristic features 
include: C1, C2, Zink-fingers 1 and 2; A, acidic domain; PH, 
pleckstrin homology domain; KD, kinase domain. In addition, 
hPKD2 contains a proline rich domain (P) at the N-terminal 
end and a serine rich region between the two zinc fingers 
(purple box). Two serine residues in the kinase domain 
(Ser689, Ser702) are thought to be phosphorylated upon acti-
vation of PKD. They were both mutated to glutamic acid in 
PKD-SE. hPKD2 contains a further possible auto-phosphor-
ylation target within the C-terminus. The presumptive ATP 
binding site, lysine at the beginning of the kinase domain 
(K572), is highlighted. It was altered to tryptophane in PKD-
kd. Numbers refer to codons; they are according to [1] for 
hPKDs and [13] for Drosophila PKD. B-E) Fidelity and level of 
expression for the different variants was analyzed in vivo by 
help of the GFP-tag. Different Gal4-driver lines were used to 
address tissue specificity of GFP-expression. The examples 
show specific GFP-expression in the posterior compartment 
of a wing imaginal disc (right half) as can be achieved by using 
the en-Gal4 driver line. For better visualization, discs are 
outlined with dotted lines. The antero-posterior (yellow line) 
and the dorso-ventral borders (purple line) are indicated in 
B). Shown are B) wild type PKD (en-Gal4/PKD-WT10-1), C) 
PKD-SE (en-Gal4/PKD-SE112-6), D) PKD-kd (en-Gal4/PKD-
kd102-1) and E) hPKD3 (en-Gal4/hPKD3X-1). Scale bar, 100 
μm.Page 3 of 13
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attempting to hatch (5 of 164). Induced within the poste-
rior compartment only, PKD-SE was fully lethal at late
pupal stage at 25°C and semilethal at 18°C (32 of 224
animals hatched). Many of the eclosed animals were
defective in wing inflation; unfolded wings typically
showed a complete lack of cross veins (Fig. 3F). Hence,
cross vein formation requires a tight regulation of PKD
activity. The ectopic veins that were caused by overexpres-
sion of PKD-kd may reflect dominant negative effects.
Overexpression of dsPKD in the posterior compartment
effected slightly undulated wings that were somewhat
shorter than the control and bent towards the posterior
(Figure 3G). Wing curvature was a consequence of a
smaller posterior compartment (compare Fig. 3A and 3G,
Fig. 4). The overall size of the posterior compartment was
decreased by about 20% compared to a wild type wing
(Fig. 4). However, cell number values (cells per area) were
unchanged compared to wild type or to the anterior com-
partment suggesting that cell size remained constant in
Defects in wing development upon PKD overexpressionFigure 3
Defects in wing development upon PKD overexpres-
sion. A) Wild type wing with five longitudinal (L1 – L5) and 
anterior and posterior cross veins (acv, pcv). The posterior 
compartment is highlighted in yellow. B) Ubiquitous PKD-
WT overexpression affects the posterior cross vein (arrow). 
C) A similar defect is observed upon overexpression of 
PKD-WT just in the posterior compartment (arrow). D) 
Overexpression of PKD-kd caused loss of veins (arrow) and 
induced ectopic veinlets (arrowhead). E) In contrast, overex-
pression of PKD-kd within the posterior compartment only 
resulted primarily in loss of veins (arrow) and only few 
ectopic veinlets (arrowhead). F) Overexpression of PKD-SE 
within the posterior compartment prevented cross vein for-
mation (arrow). G) Depletion of PKD within the posterior 
wing compartment by RNAi caused loss of wing tissue, 
resulting in a conspicuous bent of the wing when compared 
to wild type. It did not affect wing venation; however, the 
texture of the wing was altered. A dotted line marks the 
antero-posterior compartment border. H) Tissue loss was 
not influenced by concomitant overexpression of DIAP1, 
albeit the total size of the wing was increased (compare with 
G). I) In contrast, a complete rescue was observed by con-
current overexpression of PKD-WT. Genotypes are: A) da-
Gal4/+, UAS-GFP/+; B) da-Gal4/UAS-PKD-WT10-1; C) en-
Gal4/UAS-PKD-WT10-1; D) da-Gal4/UAS-PKD-kd102-1; E) en-
Gal4/UAS-PKD-kd102-1; F) en-Gal4/+, UAS-PKD-SE112-6 /+; 
G) en-Gal4/+, UAS-dsPKD124-4 /+; H) UAS-DIAP1/+, en-
Gal4/+, UAS-dsPKD124-4 /+; I) en-Gal4/UAS-PKD-WT10-1, 
UAS-dsPKD124-4 /+. Scale bar, 200 μm.
Activity of PKD-kd and PKD-SE in cell cultureFigure 2
Activity of PKD-kd and PKD-SE in cell culture. A) 
HEK293T cells were cotransfected with an expression plas-
mid encoding Flag-ss-HRP or empty vector, and PKD-kd, 
PKD-SE, or PKD-WT respectively. 24 h post-transfection, 
cells were washed and fresh medium was added. The super-
natant was analyzed for peroxidase activity after 0, 1, 3 and 6 
h by chemiluminescence. Values correspond to the mean of 
triplicate samples and error bars represent standard devia-
tion. RLU, relative light units. B) COS7 cells were transiently 
transfected with expression plasmids encoding GFP-tagged 
PKD-kd, PKD-WT and PKD-SE. Cells were fixed 24 h post 
transfection and analyzed. The images shown are stacks of 
several confocal sections. Arrow points to TGN. Enlarge-
ment (boxed) of tubules (arrowhead) induced by PKD-kd 
overexpression is shown below the figure. Scale bar, 10 μm.Page 4 of 13
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due to lowered proliferation and/or induction of apopto-
sis. Tissue loss was rescued by PKD-WT indicating that it
was indeed caused by PKD depletion (Fig. 3I and Fig. 4).
We addressed the involvement of apoptosis by concomi-
tant overexpression of Drosophila inhibitor of apoptosis 1
(DIAP1). In none of the experiments performed we
observed a full rescue (Fig. 3G,H; Fig. 4 and data not
shown). However, we noted a slight improvement:
although the wing bent remained unchanged despite
DIAP1 overexpression, the overall size of the wing was
increased (Fig. 3H). Comparing the anterior compart-
ments only, en-Gal > dsPKD was 88.6% (± 6.4% SD) of
wild type size and increased to 96.1% (± 4.5% SD) by con-
current overexpression of DIAP1.
PKD specific RNA interference during larval development 
results in loss of tissue
The smaller posterior wing compartment caused by over-
expression of dsPKD conforms to an involvement of PKD
in the regulation of cell proliferation or cell death in Dro-
sophila. In order to corroborate this finding we investi-
gated further driver lines for similar phenotypes. When
two copies of dsPKD were overexpressed along the antero-
posterior border in the wing anlagen (Fig. 5A–C), the
affected tissue, which is normally located between the
third and the fourth longitudinal vein, was partially lost in
adult wings (Fig. 5D,E). In addition, the wings were undu-
lated and uneven in texture. In this setting, we could also
show a reduction of PKD protein expression indicating
that overexpression of the RNAi construct caused indeed a
hypomorphic situation (Fig. 5A–C). However, larval wing
imaginal discs appeared fairly normal in size and the strip
of cells, where RNAi was induced, appeared as wide as in
the control suggesting that the developmental defects
occurred primarily during pupal morphogenesis (com-
pare Fig. 5B,C). We noted enrichment of activated Cas-
pase 3 along the antero-posterior boundary indicative of
apoptosis (Fig. 5F–G). At the same time, we observed a
slight decrease in BrdU incorporation, although no con-
spicuous reduction in the number of mitotic cells was
observed (Fig. 5H–K). Regarding all this, we conclude that
both, impaired proliferation as well as increased apopto-
sis was involved in generating tissue loss in the adult wing.
The partial rescue may result from insufficient DIAP1
doses or from additional stronger defects in cell prolifera-
tion primarily during metamorphosis, contributing to the
tissue loss phenotype. The reduction of tissue size was not
restricted to the wing: we observed a dramatic reduction of
the adult eye when dsPKD was overexpressed in the eye
anlagen using the ey-Gal4 driver line, too (not shown).
Human PKD can rescue loss of Drosophila PKD activity
Overexpression of Drosophila dsPKD along the antero-
posterior border in the wing imaginal discs caused a fully
penetrant wrinkled wing phenotype that was amenable to
further genetic studies (Fig. 5E). We used this phenotype
to address the question whether human hPKD2 or hPKD3
was able to replace Drosophila PKD function. This was
indeed the case. Like Drosophila PKD-WT, both human
PKDs rescued the ptc > dsPKD wing phenotype to a simi-
lar degree (Table 1). Overexpression of either construct
did not effect an apparent wing phenotype on its own.
Human PKD is thought to act downstream of Phospholi-
pase C and novel Protein Kinase C (nPKC) [1]. Moreover,
hPKD1 and hPKD2 have been recently shown to target
PI4KIIIβ [9]. However, mutants or overexpression con-
structs of the respective fly homologues are not yet availa-
ble. In addition, we asked whether concurrent
overexpression of the PKC-inhibitor PKCi increased or
decreased the PKD-RNAi defects, neither was the case
(Table 1). We conclude that PKC is not closely related to
PKD signaling at least not during wing formation in Dro-
sophila.
Rescue of wing defectsFigur  4
Rescue of wing defects. A) Calculation of RNAi-effects 
within the posterior compartment. Two examples are 
shown, a control wing (upper) and a mutant wing (lower). 
Anterior (F1, pink) and posterior (F2, yellow) compartment 
area (in pixels) was measured as depicted. The area between 
L3 and L4 was ignored since the antero-posterior boundary 
cannot be exactly determined. The F2/F1 ratio was calculated 
for each wing independently to avoid influence of natural var-
iation on wing size e.g. due to nutritional conditions. B) PKD-
RNAi was induced in the posterior compartment at 29°C or 
25°C as indicated; concurrently, PKD-WT10-2 or DIAP1 
were overexpressed. A minimum of five wings of each geno-
type was measured as depicted in a) and the mean value of 
F2/F1 was determined. The wild type ratio was taken as 
100% and the others calculated as percentage of wild type. 
Error bars represent standard deviation.Page 5 of 13
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Loss of tissue upon PKD RNAiFigure 5
Loss of tissue upon PKD RNAi. A) Schematic drawing of a wing imaginal disc, highlighting the antero-posterior (a/p) bound-
ary. Oval represents presumptive wing blade. B) Expression domain of ptc-Gal4 along the a/p boundary, visualized by overex-
pression of GFP (green). C) RNA interference was induced by overexpression of UAS-dsPKD114-5 with ptc-Gal4 and caused 
detectable reduction of PKD protein accumulation (red; arrow). D) Control wing; the antero-posterior boundary is marked by 
a dotted line; the distance between third and fourth longitudinal veins is highlighted by a double-headed arrow. E) PKD RNAi 
along the antero-posterior boundary results in tissue loss (compare double-headed arrow with control in D) and in a folded 
wing with uneven texture. F – J) Analysis of cell proliferation and apoptosis in wing discs of ptc > dsPKD larvae (G, G', I, K) ver-
sus control discs (F, F', H, J). Antibody staining against engrailed (red; F', G', J, K) highlights the border of the posterior com-
partment. Scale bar, 100 μm. F, F') Control wing disc stained for activated Caspase 3 (green) to label apoptotic cells and for 
engrailed (red) to mark the border of the posterior compartment (arrowhead). G, G') A likewise stained wing disc of ptc > 
dsPKD larvae reveals an enrichment of activated Caspase 3 along the antero-posterior boundary (arrow). H) BrdU-incorpora-
tion (green) was visualized to reveal replicating cells in a control disc. Note the zone of non-proliferation along the dorso-ven-
tral boundary as well as a slight decrease of S-phase cells along the antero-posterior boundary (arrowhead). I) In contrast to 
the control, wing discs of ptc > dsPKD larvae show a decrease of BrdU incorporation all along the ptc-stripe (arrows) indicat-
ing a downregulation of cell division. J) Control wing disc stained for phospho-Histon H3 (green) to label mitotic nuclei; the 
posterior compartment is highlighted in red (arrowhead). K) A likewise stained wing disc of a ptc > dsPKD larva shows no 
overt difference in mitotic cells compared to control neither with regard to total number nor along the antero-posterior bor-
der (arrow). Genotypes are: B) ptc-Gal4/+, UAS-GFP/+; C, E, G, G', I, K) ptc-Gal4/+, UAS-dsPKD6-4 /UAS-dsPKD6-4; D, F, F', 
H, J) ptc-Gal4/+.
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the adult retina
Human PKD is known to be involved in multiple proc-
esses, most notably in secretory transport from the trans-
Golgi network to the plasma membrane [10,11]. Recently,
we have found that the expression patterns of Drosophila
PKD are compatible with a role in secretory transport [13],
which we aimed to address experimentally. Therefore, we
investigated the consequences of a manipulation of PKD
activity on the adult retina. During late pupal develop-
ment, rhodopsin and other phototransduction proteins
are transported from the Golgi into rhabdomeres, the
light sensitive membranes of the photoreceptor cells [23].
A block in maturation or trafficking of rhodopsin results
in a degeneration of the rhabdomeres and subsequently
the retina in a light dependent manner over time [23-25].
This can be shown in sections of adult eyes. We used the
gmr-Gal4 driver line to induce the expression of the PKD
proteins behind the morphogenetic furrow within cells
that enter neuronal differentiation. No effects on the outer
eye were observed upon induction of Drosophila PKD WT,
human hPKD2 and hPKD3 or of the PKD-kd variant.
However, we noted small black dots that were restricted to
single ommatidia when PKD-SE was overexpressed (Fig.
6A,B). Induction of dsPKD in the gmr-pattern affected the
outer eye more dramatically: about a third of the flies had
one or more glossy shining patches in their eyes that
turned dark over time (Tables 2, 3). Patches appeared
necrotic and irregular (Fig. 6D). These outer eye pheno-
types were largely insensitive to inhibition of apoptosis
(Fig. 6B–E; Table 2).
Sections of the adult eyes revealed retina defects for both
genotypes (see below). We noted thinner lenses in some
ommatidia of gmr > dsPKD flies (Fig. 6B). The large black
patches in older flies were filled with cocci (Fig. 6D). Bac-
terial infection can be an explanation for the darkening
and increase in size of these patches with age and their
resistance to rescue by DIAP1 (Fig. 6D,E; Tables 2, 3). The
observed lesions in the eye lens may damage the physical
barrier of the cuticle, thereby allowing bacterial entry
more easily. Accordingly, other obvious infections were
not prevalent in dsPKD flies compared to their untreated
siblings. Alternatively, PKD could be involved in fly
immune response. However, no rescue was seen with
UAS-defensin, which has been shown to specifically com-
bat gram+bacteria [26].
Retina defects were analyzed in sections. PKD-SE overex-
pression induced striking elongation and fragmentation
of rhabdomeres (Fig. 6B), whereas PKD-RNAi resulted in
a collapse and disappearance of rhabdomeres (Fig. 6D).
Conspicuous holes were detected between the ommatidia
in both cases (Fig. 6B,D). Since the overall ommatidial
architecture appeared quite normal at low resolution, we
conclude that the retina degenerated during metamor-
phosis after being established normally during larval and
early pupal development. Accordingly, photoreceptor
cells appeared normal when visualized with anti-Elav
antisera in third instar larval eye discs of gmr > PKD-SE
animals (data not shown). Sections revealed a slight
improvement by concomitant overexpression of DIAP1;
most notably the holes disappeared (Fig. 6C,E). However,
DIAP1 had little effect on the morphology of the rhab-
domeres. Neither could it halt the fragmentation caused
by overexpression of PKD-SE nor the disintegrating result-
ing from PKD-RNAi (Fig. 6C,E). Altogether, these data
suggest that the degeneration of the adult retina is partly
caused by apoptosis, yet other mechanisms must contrib-
ute as well. This was unexpected since retinal degenera-
tion caused for example by rhodopsin mutations can be
prevented by blocking apoptosis [27].
We next asked, whether PKD-mediated retinal degenera-
tion was light and age dependent, which is typical for
defects in rhodopsin maturation or trafficking [23,24]. We
set up parallel experiments, in which we overexpressed
PKD-SE and dsPKD in complete darkness and in a normal
day-night light cycle, and examined the subsequent reti-
nal degeneration at the day of eclosion and 3, 6, 10 and
14 days later, respectively (Fig. 7, and data not shown).
We noticed that the effects of PKD-SE were largely inde-
pendent of age, however, were more severe in the light
than in the dark. Whereas the rhabdomeres of the light-
reared flies were elongated and often fragmented, those of
the dark reared flies appeared swollen and irregular. Frag-
mentation was less frequent. However, retina degenera-
tion occurred also in the dark albeit it was less severe (Fig.
7B). In contrast, the defects caused by PKD-RNAi were
both dependent on light and age since the strongest phe-
notypes were observed in the older flies that were reared
Table 1: Human PKD can replace Drosophila PKD activity
UAS-Line n 0/1 2 3
GFP-lacZ 19 0% 0% 100%
PKD-WT10-2 44 77,2% 4,6% 18,2%
PKD-SE139-2 35 94,3% 2,9% 2,8%
hPKD2II-3 22 63,6% 36,4% 0%
hPKD2X-2 16 89,0% 8,3% 2,7%
hPKD3V-1 28 79,6% 14,3% 6,1%
hPKD3X-1 21 86,5% 8,1% 5,4%
PKCi 23 0% 0% 100%
The given UAS-line was overexpressed along the antero-posterior 
border with help of the ptc-Gal4 driver line together with UAS-
dsPKD6-4. As control, ptc > dsPKD6-4 was crossed to UAS-GFP-lacZ 
and wings used for comparison. Wings of at least ten flies were 
mounted and examined at high magnification. n, number of wings 
scored. 0/1, wild type looking wing; 2, weak phenotype; 3, phenotype 
indistinguishable from control. Numbers represent percentage of 
wings with given phenotype.Page 7 of 13
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completely disappeared. In contrast, younger flies or flies
reared in the dark showed much milder signs of deteriora-
tion (Fig. 7C). Hence, PKD is important for the formation
and the maintenance of rhabdomeres where it seems to be
continuously required in light sensitive processes.
Discussion
Drosophila PKD affects wing development
Overexpression of both wild type and the kd-PKD iso-
forms interfered in particular with wing vein develop-
ment. Wing veins are established in several phases during
larval and pupal development and require the activity of a
number of signaling pathways [28-30]. One example is
the Notch signaling pathway. Overactivation of this path-
way results in loss of veins indistinguishable of pheno-
types observed for example in en > PKD-kd (Fig. 3E)
[31,32]. However, ectopic expression of proneural pro-
teins can induce ectopic veinlets similar to what is seen in
the da > PKD-kd wings [31]. Notch activity reduces those
veinlets and hence, acts in the opposite direction. There-
fore, PKD might positively regulate Notch signaling,
whereas the dominant negative activity of PKD-kd might
inhibit it. Similar phenotypes can also be a consequence
of disturbance of EGFR-signaling. For example, loss of
Table 3: Age dependency of external eye phenotypes
gmr > PKD-SEa gmr > dsPKDb
days AEc N 1–4 spotsd n 1–2 spotse ≥ 3 spots total
0–3 d 117 29,1% 170 3% 0% 3%
12–15 d 101 22,8% 248 19,3% 7,7% 27%
21 d Nd - 137 5,8% 29,2% 35%
Genotypes are gmr-Gal4/UAS-PKD-SE139-2 (a) and gmr-Gal4/+; 
dsPKD114-5/+ (b). Flies were analyzed at given times after eclosion 
(days AE) (c). Crosses were set up in parallel and performed at 25°C. 
External phenotypes scored for gmr > PKD-SE were dark spots (D) 
and for gmr > dsPKD fully black patches (e). nd, not determined.
Manipulation of PKD activity causes retina degenerationFigure 6
Manipulation of PKD activity causes retina degenera-
tion. A) Eyes of control flies have externally a smooth and 
regular appearance (left column). Tangential sections reveal 
the underlying, semi-crystalline architecture of the facets 
(center column). Seven photoreceptor cells can be distin-
guished by the centrally located rhabdomeres (arrow) that 
contain the light sensitive rhodopsin. Each facet is insulated 
by surrounding pigment cells that contain pigment granules 
(arrowhead). See enlargement in the right column. B) Over-
expression of one or several copies PKD-SE139-2 caused sin-
gle black dots that have the size of a single facet (small 
arrow). Tangential sections reveal degeneration of the retina. 
The borders between ommatidia become blurred by many 
holes; also, fusion was observed. The pigment granules seem 
to clump and no longer encircle the rhabdomeres (arrow-
head). The rhabdomeres are swollen and elongated; some 
are fragmented (arrow). Some rhabdomeres are absent and 
others degenerated. C) The defects remain largely unaltered 
when DIAP1 is overexpressed simultaneously, apart from a 
good rescue of the holes. D) Overexpression of dsPKD 
causes large black patches with a glossy surface (small 
arrow). Sections reveal massive amounts of cocci within the 
black patch (black arrowhead) underlying thinner lens (open 
arrow). Rhabdomeres are collapsed and degenerated 
(arrow); sporadic pigment granules can be seen (arrowhead). 
E) Concurrent overexpression of DIAP1 has little influence 
on the superficial appearance (arrow). However, the retina is 
somewhat more regular, which is reflected by the pigment 
granules that partly encircle the ommatidia (arrowhead). 
Moreover, rhabdomeres are well separated but many of 
them are degenerated (arrow). Genotypes are: A) wild type; 
B) gmr-Gal4/PKD-SE139-2; C) UAS-DIAP1/+, gmr-Gal4/PKD-
SE139-2; D) gmr-Gal4/+, UAS-dsPKD114-5 /+; D) UAS-DIAP1/
+, gmr-Gal4/+, UAS-dsPKD114-5 /+. Scale bar, 20 μm.
Table 2: Rescue of external eye phenotypes by Drosophila 
inhibitor of apoptosis DIAP1
genotypea phenotypeb total numberc
1) PKD-SE 31,9% 238
2) DIAP1 + PKD-SE 30,4% 194
3) dsPKD 19,7% 259
4) DIAP1 + dsPKD 19% 252
(a) Genotypes: 1) PKD-SE: gmr-Gal4/PKD-SE139-2; 2) DIAP1+ PKD-
SE: UAS-DIAP1/+; gmr-Gal4/PKD-SE139-2; 3) dsPKD: gmr-Gal4/+; 
dsPKD114-5/+; 4) DIAP1 + dsPKD: UAS-DIAP1/+; gmr-Gal4/+; 
dsPKD114-5/+. (b) For PKD-SE, eyes with black dots were counted 
and for gmr > PKD-SE, glossy and/or black patches, respectively. (c) 
Total number represents the number of flies of a given genotype 
scored.Page 8 of 13
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sion of ve induces ectopic veins [31,33]. The Ve protein is
a positive regulator of EGFR-signaling and is required for
the release of the respective ligands [34]. Hence, PKD
might be involved in the negative regulation of EGFR-sig-
naling. Finally, the dpp-pathway plays an important role
in the positioning and consolidation of veins and nota-
bly, of cross veins [28-30,35-37]. Interestingly, vein phe-
notypes caused by an overactivation of the dpp-pathway
are indistinguishable from those caused by the overex-
pression of PKD-kd [29]. Any of these pathways or all of
them may be influenced by PKD, which can be now
addressed in more detail. As cross veins are most sensitive
towards overexpression of PKD, the dpp-pathway seems
to be the most promising candidate. The altered wing tex-
ture caused by overexpression of dsPKD appears to be
non-autonomous and may reflect defects in the secretion
of extracellular matrix or wing cuticle. Shortly after
eclosion, wing epithelial cells delaminate and migrate
into the thorax. Extra-cellular matrix components are pro-
duced presumably by these migrating cells that bond ven-
tral and dorsal wing surfaces once the cells have
disappeared [38]. Disturbance of this process interferes
with wing unfolding and bonding [39]. The resultant phe-
notypes are reminiscent of defects seen upon overexpres-
sion of either PKD-SE (wing unfolding) or dsPKD (flaccid
wings) and in agreement with a role for PKD in these
processes.
Human PKD can replace Drosophila PKD activity
Mammals contain three highly related PKD isoforms that,
based on their similarity, may be functionally redundant.
However, they are differentially expressed suggesting tis-
sue specific activities [40]. The human isoforms, hPKD2
and hPKD3 rescued the wing phenotype caused by RNAi
with Drosophila PKD (Table 1). Drosophila and human
PKDs show an overall degree of similarity of about 65%,
albeit the kinase domain is well-conserved [13]. The latter
raises the possibility of an interference between dsPKD
and hPKD mRNA. Stretches of identical sequences are
rather short, however, may suffice for interference notably
with hPKD2 and less likely with hPKD3 (see Materials
and Methods) [41]. The similarity in rescue of either con-
struct is in agreement with a replacement of Drosophila
PKD function rather than a titration of the generated siR-
NAs by hPKD mRNA. Strikingly, we observed that both
hPKD proteins were predominantly cytosolic in Dro-
sophila tissues, just like the Drosophila PKD protein (Fig.
1B–E). In contrast to Drosophila PKD, hPKDs are nuclear
and cytosolic in mammalian cells [2,13]. Mammalian
cells use specific mechanisms to regulate nuclear import
of PKD that may not operate in the fly [42]. Nuclear trans-
port of PKD requires PKC and responds to G protein cou-
pled receptor (GPCR) activation [43]. In this context, it is
noteworthy that the C. elegans homologue DKF-1 is stim-
ulated directly by phorbol-esters independent of PKC [8].
It is conceivable that Drosophila PKD is activated in a sim-
ilar way.
Drosophila PKD is required for the formation and 
maintenance of rhabdomeres
Both gain and loss of function of PKD as realized by the
overexpression of the presumptive constitutively active
PKD-SE isoform and by dsPKD-constructs, respectively,
caused a degeneration of the adult retina. Apparently, the
fly's retina is highly sensitive towards PKD doses. The phe-
notypes were quite distinct suggesting that they were not
just a consequence of interference with the trafficking of
rhodopsin. In this case, we would have expected a degen-
eration of rhabdomeres in a light and age dependent man-
ner that, in addition, should be amenable to rescue by
inhibition of apoptosis [23,24,27]. In contrast, the defects
Dependence of retinal degeneration on light and ageFigure 7
Dependence of retinal degeneration on light and age. 
Flies were raised in twelve-hour day-night cycle (left column; 
labelled with black and white bar) or in complete darkness 
(right column; black bar) and aged for several days at 25°C. 
Time points shown: 3d, 0–3 days after hatching; 14d, 10–14 
days after hatching. Enlargements of each 4 × 4 ommatida are 
shown to highlight the defects. A) Eyes of control flies: Note 
the regular architecture of ommatidia, which is independent 
of light and age. B) PKD-SE was overexpressed behind the 
morphogenetic furrow. In the light (left), rhabdomeres are 
elongated and sometimes fragmented or completely absent. 
In the dark (right) these phenotypes are less extreme but still 
detectable. They are largely independent of age. C) dsPKD 
was likewise induced in a light-dark cycle (left) and in the 
dark (right). Note degeneration of rhabdomeres in the light 
reared, 14 days old flies. The degeneration is less severe in 
younger flies or those kept in the dark. Genotypes are: A) 
gmr-Gal4/+; B) gmr-Gal4/PKD-SE139-2; C) gmr-Gal4/+, UAS-
dsPKD114-5 /+. Scale bar, 10 μm.Page 9 of 13
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were only slightly ameliorated by DIAP1. We cannot
exclude, however, that the dose of DIAP1 was insufficient
for a full rescue. Overall, the retinal degeneration seemed
not to be caused primarily by interference with rhodopsin
trafficking. Whereas PKD downregulation resembled
defects in rhodopsin, the overactivation of PKD caused
the elongation and sometimes fragmentation of the rhab-
domeres. This phenotype is more reminiscent of muta-
tions in bifocal (bif) and Amphiphysin (Amph) [44,45]. Bif
encodes a presumptive cytoskeletal regulator and associ-
ates with actin filaments. Amph is localized to actin-rich
membrane domains and is involved in their structural
organization. Together, these two genes are required to
organize a localized actin cytoskeleton and eventually
form the microvilli stacks that build up the rhabdomeres
[44,45]. Based on the similarity of the phenotypes, we
propose that manipulation of PKD somehow affects the
cytoskeleton and thereby the formation and maintenance
of rhabdomeres rather than being involved in rhodopsin
trafficking. In fact, rhodopsin itself plays an essential
structural role in rhabdomere morphogenesis that
involves F-actin and the unconventional myosin ninaC
[25]. Accordingly, mutations affecting either rhodopsin,
ninaC or components involved in establishment of the
microtubule network, i.e. F-actin capping proteins, cause
a likewise retinal degeneration [24,25,46]. An involve-
ment of PKD in cytoskeletal dynamics would attribute to
both, the gain and the loss of function phenotypes. Inter-
estingly, mammalian PKD1 is associated with the F-actin
binding proteins cortactin and paxillin in invasive breast
cancer cells where it may regulate cell adhesion and motil-
ity [47]. In the context of photoreceptor axon guidance,
Bif is phosphorylated and thereby regulated by the Ser/
Thr kinase misshapen [48]. It is tempting to speculate that
PKD might likewise regulate Bif, thereby implementing its
influence on the actin cytoskeleton. Further investigations
on the relationship of PKD and Bif in Drosophila may help
to elucidate the role of human PKDs in the regulation of
the cytoskeleton and metastasis.
Conclusion
Our overexpression experiments reveal an involvement of
Drosophila PKD in many aspects of development. The
effects on vein formation argue for a regulatory input of
PKD on one or several signaling pathways, for example
dpp-, Notch- or EGFR-pathways. Tissue loss for example
in the wing caused by PKD RNAi suggests a role in prolif-
eration and regulation of apoptosis, which is corrobo-
rated by respective antibody stainings. A striking
degeneration of the adult retina was observed upon
downregulation of PKD by RNAi or by overexpression of
the presumptive constitutively active PKD-SE isoform. In
both cases the formation and maintenance of the rhab-
domeres was affected. The observed phenotypes conform
to a role of PKD in the regulation of actin dynamics in
agreement with similar findings in mammalian cells.
Although the eye phenotypes are most likely not a conse-
quence of a disturbed trafficking of rhodopsin, PKD might
be involved in the transport of other basolateral cargo for
example in extracellular matrix formation of the adult
wing. Despite a considerable divergence, human hPKD2
and hPKD3 could largely restore Drosophila PKD RNAi-
phenotypes. In summary, our studies are in accordance
with a role of PKD in the regulation of cell proliferation
and death and hence, the differentiation of various tissues
during Drosophila development. Most interestingly, the
potential involvement of PKD in the regulation of
cytoskeletal dynamics may help to unravel the role of
human PKDs in cell motility and metastasis.
Methods
Fly strains and crosses
Flies were obtained from the Bloomington stock center, if
not mentioned otherwise; information on strains can be
found in the flybase. Tissue specific overexpression or
RNAi induction was achieved with the Gal4/UAS system
[14,20] using da-Gal, en2.4-Gal4e16E, ey-Gal4 (gift from U.
Walldorf), gmr-Gal4, and ptc559-Gal4 as driver lines.
Crosses were performed at 18°C, 25°C or 29°C. The fol-
lowing UAS-lines were used: UAS-PKD-WT [13], UAS-
PKD-kd, UAS-PKD-SE, UAS-hPKD2, UAS-hPKD3, UAS-
dsPKD (see below), UAS-DIAP1 (gift from A. Müller),
UAS-defensin (gift from B. Lemaitre), UAS-PKCi.B4A and
UAS-GFP.
Generation of overexpression constructs and transgenic 
lines
PKD overexpression constructs fused to GFP were gener-
ated as outlined before [13]. Briefly, PKD cDNA was
mutated to PKD-kd using the primer pair KWUP 5'-GAG
GTG GCC ATC TGG GTG ATC GAC AAA -3' and KWLO 5'-
TTT GTC GAT CAC CCA GAT GGC CAC CTC – 3' and to
PKD-SE using the primer pair SEUP 5'- ATC GGC GAG
AAG GAG TTC CGG CGC GAG GTG GTT GGC ACT -3'
and SELO 5'-AGT GCC AAC CAC CTC GCG CCG GAA
CTC CTT CTC GCC GAT -3' applying the QuickChange® II
XL site-directed mutagenesis kit (Stratagene). Mutant
cDNA was shuttled into pEGFP-N1 vector (Clontech) and
pUAST vector [14] as described for PKD-WT [13]. pUAST-
hPKD2 and pUAST-hPKD3 were generated from plasmids
pEGFP-N1-PKD2 and pEGFP-N1-PKD3 [9]; cDNA encod-
ing hPKD2 was shuttled as EcoR I/Not I fragment into like-
wise digested pUAST. cDNA encoding hPKD3 was
shuttled as Sac I (blunted by T4 DNA polymerase)/Not I
fragment into Eco RI (blunted)/Not I pUAST vector. All
constructs were sequence verified. Several transgenic fly
lines were generated for each construct and tested for their
expression in vivo. Representative lines that had similar
expression levels in imaginal discs as well as in WesternPage 10 of 13
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PKD-kd1–2, PKD-kd101-2, PKD-SE112-6, PKD-SE139-2,
dsPKD114-5, dsPKD124-4, hPKD2II-2, hPKD2X-2, hPKD3I-3,
and hPKD3X-1.
Generation of RNAi construct and transgenic lines
Cloning of a PKD RNAi construct followed the strategy
outlined in before [20]. Using the primer pair dsPKDUP
5'-GGA TTC AAA CAG GAG GCG CAG CTG AAG AAC G-
3' and dsPKDLO 5'-GGT ACC GGT GTT GGC GCT GCA
GCT GAT TAA CTC-3', an 833 nucleotides (nt) spanning
C-terminal part of the PKD cDNA (nt 1743 – 2576 starting
with A1TG, corresponding to codons 582–836 plus 69 nt
from 3' UTR) was cloned into pHIBS. It was shuttled in
inverse orientation as Bam HI/Kpn I fragment into like-
wise opened pUAST vector after destroying an internal
Xho I site within the 3' UTR of PKD (position 2537). In a
second step, the PKD segment (nt 1743 – 2537) plus the
Hairless intron [49] was cloned in direct orientation as Sal
I/Xho I fragment into pUAST opened with Xho I. The final
construct was sequence verified. Several transgenic lines
were generated according to standard methods. Pheno-
types were obtained at 25°C to 29°C in the presence of
two or more copies of the dsPKD construct.
The DNA segment cloned in dsPKD showed an overall
sequence identity of about 70% to both hPKD2 and
hPKD3, respectively [13]. A pairwise alignment of hPKD2
with the Drosophila ds-segment showed a single 24
nucleotide stretch of full identity, however, with lower 5'
than 3' stability of the sense strand, making it more likely
guide than passenger strand. Moreover, we found 4
stretches of 19 or more nucleotides allowing a single mis-
match. In contrast, the hPKD3-dsPKD pair showed a max-
imum of 11 identical nucleotides and not a single stretch
of at least 19 identities allowing a single mismatch. Pre-
dictions for potent siRNAs were used to search for optimal
pairs, however, not a even one was found that conforms
to the signatures of a potent siRNA [41].
Activity of PKD constructs in human tissue culture
Cell culture and transfection
HEK293T and COS7 cells were grown in RPMI supple-
mented with 10% fetal calf serum (FCS) in a humified
atmosphere containing 5% CO2. HEK293T cells were
transfected using TransIT293 reagent (Mirus) according to
the manufacturer's instructions. For immunofluores-
cence, COS7 cells were grown on glass coverslips for 24
hours and transfected with Lipofectamine 2000 reagent
(Invitrogen).
HRP transport assay
HEK293T cells were cotransfected with ss-HRP-Flag plas-
mid and empty pEGFP-N1 vector, pEGFP-N1-PKD-kd and
pEGFP-N1-PKD-SE at a ratio of 1: 6.5, respectively. 24 h
post-transfection cells were washed with serum-free
media and HRP secretion was quantified after 0, 1, 3 and
6 h by incubation of clarified cell supernatant with ECL
reagent (Pierce). Measurements were done with a lumi-
nometer (Lucy2, Anthos) at 450 nm.
Fluorescence microscopy
Cells were washed with phosphate buffered saline (PBS),
fixed in 4% paraformaldehyde in PBS at room tempera-
ture for 10 min and washed with PBS. Coverslips were
mounted in Fluoromount G (Southern Biotechnology)
and cells were analyzed on a confocal laser scanning
microscope (TCS SL, Leica) using 488 nm excitation and
a 40.0/1.25 HCX PL APO objective lens. Images were
processed with Adobe Photoshop.
Expression analyses in fly tissues
PKD UAS-lines were induced ubiquitously using the da-
Gal4 driver. Expression levels were monitored in Western
blots loaded with protein extracts of each 100 first instar
larvae using anti-GFP antibodies (Santa Cruz Biotechnol-
ogy). For loading control, the blot was probed simultane-
ously with anti-gro antibodies (developed by C.
Delidakis, obtained from DSHB, University of Iowa, Dept.
Biol. Sci., Iowa City, IA 52242, USA). For in situ detection,
PKD UAS-lines were crossed with en-Gal4, which drives
expression in posterior compartments of imaginal discs.
Discs were fixed for 5–10 minutes in 4% paraformalde-
hyde in phosphate buffered saline (PBS) and mounted in
vectashield (Vector lab). To monitor downregulation of
PKD by RNAi, the UAS-dsPKD6-4 line was crossed with ptc-
Gal4 and imaginal discs of third instar larval offspring
processed according to standard methods [20] using
mouse polyclonal anti-PKD antiserum [13]. The posterior
compartment of wing discs was stained with monoclonal
anti-En/Inv antibodies (Clone 4D9; developed by C.
Goodman, obtained from DSHB, University of Iowa,
Dept. Biol. Sci., Iowa City, IA 52242, USA). Apoptotic
cells were labelled with anti-activated Caspase 3 antibod-
ies (Cell Signaling Technology). Mitotic nuclei were
detected with rabbit polyclonal antiserum directed against
phosphorylated Histon H3 (Upstate Chemicals). BrdU
incorporation was performed as described before [50]
using monoclonal anti-BrdU antibodies (Clone G3G4,
developed by S.J. Kaufman, obtained from DSHB). Devel-
oping photoreceptor cells were stained in eye imaginal
discs using anti-Elav antibodies (Clone 7E8A10, devel-
oped by G. Rubin, obtained from DSHB). Secondary anti-
bodies coupled to alkaline phosphatase, fluorescein or
Cy3 were purchased from Jackson Laboratories (Dian-
ova). Fluorescent tissue was analyzed by confocal micros-
copy (BioRad MRC1024 on Zeiss Axioskop). Figures were
assembled using Corel Photo Paint and Corel Draw soft-
ware.Page 11 of 13
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Samples of at least fifty flies of each genotype were
inspected with low magnification microscopy (up to 40
fold). For closer examination, wings of ten or more flies
were mounted and ten or more eyes were sectioned,
respectively. Wings were dried in ethanol, mounted in
Euparal (Merck), cleared over night and viewed with a
Zeiss Axioskop using Normarski optics or phase contrast.
Wing size, cell size and number were determined as
described earlier [51], except that ImageJ software was
used for pixel measurements. Fly heads were viewed with
a WILD stereomicroscope. Pictures were taken with a Pix-
era digital camera (Optronics) using the Pixera Viewfinder
Version 2.0 software. Sections of adult heads were per-
formed as described before [52]. Figures were compiled
using Corel Photo Paint and Corel Draw software.
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